Related Experiment Video
Updated: Sep 21, 2025
07:35
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
10.4K
Therapeutic Targets in Allergic Conjunctivitis
Bisant A Labib1, DeGaulle I Chigbu1
1Pennsylvania College of Optometry, Salus University, Elkins Park, PA 19027, USA.
Pharmaceuticals (Basel, Switzerland)
|May 28, 2022
Summary
Allergic conjunctivitis (AC) involves immune responses causing eye inflammation and discomfort. Understanding its immune mechanisms is key to developing better treatments for this common condition.
Area of Science:
- Ophthalmology
- Immunology
- Allergy
Background:
- Allergic conjunctivitis (AC) is a prevalent ocular condition triggered by allergens.
- It involves immunoglobulin E-mediated mast cell degranulation, releasing inflammatory mediators.
- Chronic or refractory cases can lead to vision-threatening ocular surface complications.
Purpose of the Study:
- To review current therapeutic strategies for allergic conjunctivitis.
- To elucidate the pathological and immune mechanisms underlying AC.
- To identify cellular and molecular targets for novel AC therapies.
Main Methods:
- Literature review of published articles on AC treatments and mechanisms.
- Analysis of immune pathways involved in AC pathogenesis.
- Focus on cellular and molecular targets for therapeutic intervention.
Main Results:
- AC pathogenesis involves mast cell degranulation and release of histamine, cytokines, and chemokines.
- Current treatments often require multiple agents for adequate control.
- Potential therapeutic targets include chemokine receptors, cytokine receptors, tyrosine kinases, and integrins.
Conclusions:
- A comprehensive understanding of AC's immune mechanisms is crucial for developing targeted therapies.
- Identifying specific cellular and molecular targets can lead to more effective treatments.
- Further research into these targets may improve management and patient quality of life.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
619
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
619
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
522
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
522
01:17Drugs Used in Lower Respiratory Disorders: Overview
637
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
637
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
938
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
938
01:27Allergic Drug Reactions
1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
533
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
533